SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-043560
Filing Date
2024-05-15
Accepted
2024-05-15 16:01:23
Documents
92
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0205908-20f_scinai.htm   iXBRL 20-F 1881441
2 DESCRIPTION OF SHARE CAPITAL ea020590801ex2-3_scinai.htm EX-2.3 114363
3 CERTIFICATION ea020590801ex12-1_scinai.htm EX-12.1 10521
4 CERTIFICATION ea020590801ex12-2_scinai.htm EX-12.2 10348
5 CERTIFICATION ea020590801ex13-1_scinai.htm EX-13.1 4041
6 CERTIFICATION ea020590801ex13-2_scinai.htm EX-13.2 3999
7 CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A MEMBER F ea020590801ex15-1_scinai.htm EX-15.1 3817
8 CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A M ea020590801ex15-2_scinai.htm EX-15.2 2701
9 LETTER, FROM KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A ea020590801ex16-1_scinai.htm EX-16.1 3290
10 SCINAI IMMUNOTHERAPEUTICS POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATIO ea020590801ex97-1_scinai.htm EX-97.1 31227
11 GRAPHIC image_001.jpg GRAPHIC 6121
12 GRAPHIC image_002.jpg GRAPHIC 2265
13 GRAPHIC image_003.jpg GRAPHIC 2620
14 GRAPHIC ex15-1_001.jpg GRAPHIC 5516
15 GRAPHIC ex15-1_002.jpg GRAPHIC 2620
  Complete submission text file 0001213900-24-043560.txt   6847313

Data Files

Seq Description Document Type Size
16 XBRL SCHEMA FILE scni-20231231.xsd EX-101.SCH 69304
17 XBRL CALCULATION FILE scni-20231231_cal.xml EX-101.CAL 34154
18 XBRL DEFINITION FILE scni-20231231_def.xml EX-101.DEF 281946
19 XBRL LABEL FILE scni-20231231_lab.xml EX-101.LAB 573631
20 XBRL PRESENTATION FILE scni-20231231_pre.xml EX-101.PRE 291676
96 EXTRACTED XBRL INSTANCE DOCUMENT ea0205908-20f_scinai_htm.xml XML 570810
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
Scinai Immunotherapeutics Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-37353 | Film No.: 24950134
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)